Nevro
NVRO
#8367
Rank
HK$1.74 B
Marketcap
HK$45.46
Share price
0.00%
Change (1 day)
-37.38%
Change (1 year)
Categories

P/E ratio for Nevro (NVRO)

P/E ratio on December 6, 2025 (TTM): -1.91

According to Nevro 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.91475. At the end of 2023 the company had a P/E ratio of -8.37.

P/E ratio history for Nevro from 2014 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-8.37-101.48%
2022566-2730.74%
2021-21.5-69.07%
2020-69.599.91%
2019-34.845.75%
2018-23.9-56.46%
2017-54.8-15.54%
2016-64.9145.05%
2015-26.51431.06%
2014-1.73

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Intuitive Surgical
ISRG
74.4-3,986.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abiomed
ABMD
64.8-3,484.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
33.1-1,826.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Orthofix Medical
OFIX
-5.28 175.78%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.